19 - 21 October, 2026
The Westin Miyako KyotoKyoto, Japan Kaori MukaiPrincipal Scientist at Sanofi, USASpeaker
Profile
Kaori Mukai is a Principal Scientist in Immune Checkpoint Cluster, Immunology & Inflammation Research at Sanofi in Cambridge, USA. She holds a PhD in Immunology from Tokyo Medical and Dental University in Japan. After her postdoc research at Stanford University in USA, she joined Sanofi. At Sanofi she has led multiple new drug development projects for inflammatory diseases.
Agenda Sessions
Targeted protein degradation through site-specific antibody conjugation with mannose 6-phosphate glycan
, 14:00View Session